Skip to main content

Table 3 Use of healthcare services during pretreatment and follow-up

From: Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study

 

Pretreatment

Follow-Up

P-Value

Office visits

   

   Psychiatrists

   

Mean (SD)

1.0 (3.3)

2.1 (5.1)

< 0.01

Median (IQR)

0 (0, 0)

0 (0, 2)

 

   Internists

   

Mean (SD)

0.9 (2.3)

1.1 (2.9)

0.01

Median (IQR)

0 (0, 1)

0 (0, 1)

 

   General practitioners

   

Mean (SD)

1.9 (3.3)

2.4 (3.7)

< 0.01

Median (IQR)

1 (0, 3)

1 (0, 4)

 

   Other

   

Mean (SD)

9.1 (12.1)

11.1 (14.2)

< 0.01

Median (IQR)

5 (2, 12)

6 (2, 15)

 

   Total

   

Mean (SD)

12.6 (13.2)

16.3 (15.5)

< 0.01

Median (IQR)

8 (4, 16)

11 (6, 21)

 

Other outpatient office visits

   

   Mean (SD)

1.3 (2.6)

1.5 (3.5)

0.01

   Median (IQR)

0 (0, 2)

0 (0, 2)

 

Total outpatient office visits

   

   Mean (SD)

13.5 (13.6)

17.3 (16.0)

< 0.01

   Median (IQR)

9 (5, 17)

12 (6, 23)

 

ED visits

   

   Mean (SD)

0.3 (1.1)

0.3 (1.1)

0.28

   Median (IQR)

0 (0, 0)

0 (0, 0)

 

Hospitalizations

   

   Mean (SD)

0.3 (2.0)

0.4 (2.4)

0.04

   Median (IQR)

0 (0, 0)

0 (0, 0)

 
  1. GAD: Generalized anxiety disorder; SD: Standard deviation; ED: Emergency department; IQR: Interquartile range